Veradigm (NASDAQ:MDRX) Stock Passes Above Two Hundred Day Moving Average - Should You Sell?

Key Points

• Veradigm Inc. (NASDAQ:MDRX) shares have surpassed their 200-day moving average, with the stock trading at $4.90, compared to the moving average of $4.59.
• Analysts from Wall Street Zen have initiated coverage with a "hold" rating, and the consensus target price for the stock stands at $13.00.
• Veradigm is a healthcare technology company that provides IT solutions including electronic health records and population health management services to healthcare organizations.

Veradigm Inc. (NASDAQ:MDRX - Get Free Report)'s share price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $4.59 and traded as high as $4.90. Veradigm shares last traded at $4.90, with a volume of 3,061 shares changing hands.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen initiated coverage on shares of Veradigm in a research note on Tuesday, May 20th. They issued a "hold" rating on the stock. One research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, Veradigm currently has an average rating of "Hold" and an average price target of $13.00.

Veradigm Stock Performance

The stock has a 50-day moving average of $4.76 and a 200-day moving average of $4.59.

About Veradigm

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.